The purpose of this clinical study was to find a relationship between
soluble tumor necrosis factor (TNF) receptor, deep venous thrombosis (
DVT), and pulmonary emboli (PE). Clinical diagnosis of deep venous thr
ombosis and pulmonary emboli is a major dilemma for the clinician. Mos
t existing tests are technician dependent, are expensive, or require s
ophisticated equipment. Advances in molecular biology will permit inve
stigation of the value of TNF receptor as a test for screening, diagno
sis, and evolution of DVT and PE. Forty patients with diagnosis of DVT
, documented: by real-time ultrasound imaging, were the subject of thi
s clinical study. Five cc of plasma from each patient was studied by e
nzyme-linked immunosorbent assay (Elisa) for measurement of soluble TN
F receptor. Significantly increased concentration of plasma-soluble TN
F receptor was present in patients with DVT as opposed to normal indiv
iduals. The-re was a close relationship between plasma concentration o
f soluble TNF receptor and evaluation of the disease. In this prelimin
ary clinical study, it appears that plasma measurement of soluble TNF
receptor could be used as a clinical;test for diagnosis of DVT and PE.